Seiichiro Fujimoto
Memorial Hospital of South Bend
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Seiichiro Fujimoto.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2003
Soromon Kataoka; Hideto Yamada; Nobuhiko Hoshi; Masataka Kudo; Hitoshi Hareyama; Noriaki Sakuragi; Seiichiro Fujimoto
OBJECTIVE The aim of this study was to elucidate the clinical characteristics of uterine leiomyomas having abnormal chromosome karyotype. STUDY DESIGN A total of 394 myomas were obtained from 213 patients for cytogenetic analysis. The size (number of nodules=144), histopathology (n=302), and gonadotropin-releasing hormone analogue (GnRHa)-response (n=58) were investigated in relation to chromosome karyotype in myomas. RESULTS 302 myomas from 166 patients were successfully karyotyped. A total of 21 myomas from 21 patients showed abnormal chromosome karyotype. The high frequencies of involved chromosomes 12, 14, 1, 7 were observed. The diameters of myomas with abnormal karyotype were significantly larger than those of myomas with normal karyotype. The frequency of the degeneration in myomas with abnormal karyotype was significantly higher than that with normal karyotype. The reduction rate in size of myomas by GnRHa treatments did not differ between the two types (karyotype normal versus abnormal) of nodules. CONCLUSIONS Chromosomally abnormal myomas were larger in diameter and showed a higher frequency of degeneration, suggesting that the cytogenetic background in uterine leiomyoma affects a tumors growth potential.
The Ovary (Second Edition) | 2003
Kazuhira Okamoto; Noriaki Sakuragi; Seiichiro Fujimoto
This chapter investigates the long-term prognosis of the physiologic function of transposed ovaries in patients with cervical cancer and the risk factors of impairment of ovarian function after radical hysterectomy (RH), and analyzes the survival of patients treated with RH with ovarian transposition. The hormonal function of transposed ovaries and survival of patients treated with RH and ovarian transposition in cervical carcinoma is followed up prospectively. In the treatment of cervical cancer, gynecologists should make an effort to maintain the quality of life (QOL) of patients by maximally preserving the physiologic functions of the pelvic organs while pursuing a cure of the disease. Bilateral oophorectomy and resultant loss of ovarian function in young patients will cause climacteric-like symptoms, decrease in bone mineral density, hypercholesterolemia, increased risk of ischemic heart disease, and adverse psychological effects. In cervical cancer, especially in squamous cell carcinoma, risk of ovarian metastasis is quite low, while there are several reports of ovarian metastasis in adenocarcinoma of the cervix.
Hokkaido University Medical Library series | 1998
Seiichiro Fujimoto; Tatsuro Kishida; Tadashi Sagawa
The Journal of the Japanese Society of Clinical Cytology | 1994
Hitoshi Hareyama; Mamiko Kume; Toshihiro Ohkohchi; Naoki Takeda; Masashi Nishiya; Hitoshi Ohkubo; Noriaki Sakuragi; Satoru Makinoda; Seiichiro Fujimoto
/data/revues/00029378/v188i5/S000293780300200X/ | 2011
Yukiharu Todo; Noriaki Sakuragi; Ryutaro Nishida; Takashi Yamada; Yasuhiko Ebina; Ritsu Yamamoto; Seiichiro Fujimoto
/data/revues/00029378/v177i6/S0002937897700826/ | 2011
Tadashi Matsuda; Takeo Nakajima; Satoshi Hattori; Kaoru Hanatani; Yuichiro Fukazawa; Kunihiko Kobayashi; Seiichiro Fujimoto
Molecular and Cellular Endocrinology | 2003
Seiichiro Fujimoto
日本産科婦人科學會雜誌 | 2002
Masato Mikuni; Maki Ishimoto; Kenrokuro Mitsube; Masataka Kudo; Noriaki Sakuragi; Hisanori Minakami; Seiichiro Fujimoto
日本産科婦人科學會雜誌 | 2002
Kenrokuro Mitsube; Masato Mikuni; Masataka Kudo; Seiichiro Fujimoto
Acta Obstetrica et Gynaecologica Japonica | 2002
Masato Mikuni; Seiichiro Fujimoto; Toshiko Toda; Yoshie Kohno; Naoki Terakawa; Mutsuo Ishikawa; Kazuo Sengoku